The tyrosine kinase receptor AXL is tightly coexpressed with FRA-1 in a variety of invasive cancer cell lines, including muscle-invasive bladder carcinoma cells, in which AXL was originally identified as an FRA-1 transcriptional target involved in the control of cancer cell motility [94]. This evidence concerns the gene AXL and cancer.